Oppenheimer Downgrades Edwards Lifesciences to Perform
Oppenheimer analyst Suraj Kalia downgrades Edwards Lifesciences (NYSE:EW) from Outperform to Perform.
Earnings Scheduled For October 27, 2022
Companies Reporting Before The Bell
• Janus Henderson Gr (NYSE:JHG) is expected to report quarterly earnings at $0.48 per share on revenue of $494.27 million.
Mizuho Initiates Coverage On Edwards Lifesciences with Buy Rating, Announces Price Target of $100
Mizuho analyst Anthony Petrone initiates coverage on Edwards Lifesciences (NYSE:EW) with a Buy rating and announces Price Target of $100.
Canaccord Genuity Maintains Hold on Edwards Lifesciences, Lowers Price Target to $91
Canaccord Genuity analyst William Plovanic maintains Edwards Lifesciences (NYSE:EW) with a Hold and lowers the price target from $106 to $91.
Jefferies Initiates Coverage On Edwards Lifesciences with Buy Rating, Announces Price Target of $110
Jefferies analyst Matthew Taylor initiates coverage on Edwards Lifesciences (NYSE:EW) with a Buy rating and announces Price Target of $110.
HC Wainwright Cuts Price Target On This Stock By 50%? Also This Analyst Slashes PT On Cisco
Barclays cut the price target on Cisco Systems, Inc. (NASDAQ: CSCO) from $56 to $46. Barclays analyst Tim Long downgraded the stock from Overweight to Equal-Weight. Cisco shares rose 0.1% to $41.61 in pre-market trading.